Pfizer-Wyeth talks could stir restive rivals

NEW YORK (Reuters) – News that Pfizer Inc is in talks to acquire Wyeth for more than $60 billion may flush out other bidders for the U.S. drugmaker and trigger a long-predicted consolidation in the pharmaceutical industry.

Leave a Reply